Skip to main content
. 2015 Nov 9;5:16553. doi: 10.1038/srep16553

Figure 4. Kaplan-Meier analysis for MFS of breast cancer patients using the nine-lncRNA signature in the subgroups stratified by ER status.

Figure 4

(A) Kaplan-Meier curves for breast cancer patients with ER-negative status (n = 239). (B) Kaplan-Meier curves for breast cancer patients with ER-positive status (n = 508). The differences between the two curves were access by the two-sided log-rank test. The number of patients at risk was listed below the survival curves.